Cargando…

OR10-006 - Canakinumab in patients with TRAPS

Detalles Bibliográficos
Autores principales:	Lachmann, HJ, Obici, L, Meini, A, Tormey, V, Abrams, K, Davis, N, Andrews, C, Bhansali, SG, Gattorno, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953131/ http://dx.doi.org/10.1186/1546-0096-11-S1-A189

Ejemplares similares

Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps
por: Gattorno, M, et al.
Publicado: (2014)

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
por: Gattorno, Marco, et al.
Publicado: (2017)

PW02-021 - SAA1 is the strongest predictor of AA in TRAPS
por: Obici, L, et al.
Publicado: (2013)

OR10-005 - Treatment responses in TRAPS: Eurofever/ Eurotraps
por: Lachmann, HJ, et al.
Publicado: (2013)

OR7-006 – Autophagy as a player in inflammation in TRAPS
por: Bachetti, T, et al.
Publicado: (2013)

Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
por: Torene, Rebecca, et al.
Publicado: (2017)

PW02-008 - TRAPS in the real world: an international registry
por: Lachmann, HJ, et al.
Publicado: (2013)

Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
por: Lachmann, H, et al.
Publicado: (2015)

PW02-006 - PAPA syndrome clinical spectrum and IL1B release
por: Omenetti, A, et al.
Publicado: (2013)

OR10-004 - Circulating micrornas in TRAPS
por: Lucherini, OM, et al.
Publicado: (2013)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

OR10-002 - A novel TNFR1 transcript of TRAPS gene
por: Rittore, C, et al.
Publicado: (2013)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

P02-008 - Dramatic response to canakinumab in MKD
por: Makay, B, et al.
Publicado: (2013)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
por: Hashkes, PJ, et al.
Publicado: (2013)

PW01-006 – The effect of colchicine on physical growth in FMF
por: Cakar, N, et al.
Publicado: (2013)

P02-024 - Clinical impact of V198M mutation in NLRP3 gene
por: Caorsi, R, et al.
Publicado: (2013)

P02-027 - Quality of life in CAPS treated by Canakinumab
por: Marsaud, C, et al.
Publicado: (2013)

P01-006 – MEFV mutation detection in Arabic patients
por: Taha, R, et al.
Publicado: (2013)

OR6-006 – IL36RN alleles in skin auto-inflammation
por: Capon, F, et al.
Publicado: (2013)

PW02-014 - Long term outcome and quality of life in TRAPS
por: Lane, T, et al.
Publicado: (2013)

P02-019 - Detection of risk factors for AA-amyloidosis
por: Németh, S, et al.
Publicado: (2013)

PW03-006 - IL-1-B inhibition in Schnitzler’s syndrome
por: De Koning, HD, et al.
Publicado: (2013)

OR11-006 - A mutation in NLRP1A causes autoinflammation
por: Masters, SL, et al.
Publicado: (2013)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

P02-006 - A novel PSTPIP1 mutation in PAPA syndrome
por: Fathalla, B, et al.
Publicado: (2013)

P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO
por: Kostik, MM, et al.
Publicado: (2013)

PW02-022 - Recurrent fever syndromes: multiple gene mutations
por: Bohm, M, et al.
Publicado: (2013)

P02-026 - Model-based characterization of the PKPD relationship for canakinumab in CAPS: a step towards personalized
por: Gautier, A, et al.
Publicado: (2013)

OR10-001 - Altered mitochondrial ROS and metabolism in TRAPS
por: Siegel, R, et al.
Publicado: (2013)

P03-017 - Health related quality of life in adult with HRFS
por: Lachmann, HJ, et al.
Publicado: (2013)

PW03-018 – Efficacy of Anakinra in recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

OR14-002 - ANTI IL-1 therapies and pregnancy outcome
por: Lachmann, HJ, et al.
Publicado: (2013)

P02-010 - A novel 24 nucleotide deletion in the TNFRSF1A
por: Rowczenio, DM, et al.
Publicado: (2013)

PW01-021 – The phenotype of FMF due to deletion M694
por: Lachmann, HJ, et al.
Publicado: (2013)

006 PP: COLLABORATION IN MUSEUMS AND HEALTH RESEARCH
por: Morse, N, et al.
Publicado: (2017)

PW03-020 – A decade of ANTI-IL-1 therpay for CAPS in the UK
por: Lane, T, et al.
Publicado: (2013)

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020)

CompTIA Network+ N10-006
por: Dulaney, Emmett A
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s5v0ijrgeuml8ak2l4uc338oiu